Li Bo, Huang Ai-Ling, Zhang Yi-Long, Li Zeng, Ding Hai-Wen, Huang Cheng, Meng Xiao-Ming, Li Jun
Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, 230000 Hefei, China.
The Key Laboratory of Anti-Inflammatory and Immune Medicines, Ministry of Education, 230000 Hefei, China.
Molecules. 2017 Jun 26;22(7):1067. doi: 10.3390/molecules22071067.
In this study we designed and synthesized a series of new hesperetin derivatives on the basis of the structural characteristics of acetylcholinesterase (AChE) dual-site inhibitors. The activity of the novel derivatives was also evaluated. Results showed that the synthesized hesperetin derivatives displayed stronger inhibitory activity against AChE and higher selectivity than butyrylcholine esterase (BuChE) (selectivity index values from 68 to 305). The Lineweaver-Burk plot and molecular docking study showed that these compounds targeted both the peripheral anionic site (PAS) and catalytic active site (CAS) of AChE. The derivatives also showed a potent self-induced β-amyloid (Aβ) aggregation inhibition and a peroxyl radical absorbance activity. Moreover, compound significantly protected PC12 neurons against H₂O₂-induced cell death at low concentrations. Cytotoxicity assay showed that the low concentration of the derivatives does not affect the viability of the SH-SY5Y neurons. Thus, these hesperetin derivatives are potential multifunctional agents for further development for the treatment of Alzheimer's disease.
在本研究中,我们基于乙酰胆碱酯酶(AChE)双位点抑制剂的结构特征,设计并合成了一系列新的橙皮素衍生物。还评估了这些新型衍生物的活性。结果表明,合成的橙皮素衍生物对AChE表现出更强的抑制活性,且比丁酰胆碱酯酶(BuChE)具有更高的选择性(选择性指数值为68至305)。Lineweaver - Burk图和分子对接研究表明,这些化合物靶向AChE的外周阴离子位点(PAS)和催化活性位点(CAS)。这些衍生物还表现出强大的自诱导β - 淀粉样蛋白(Aβ)聚集抑制作用和过氧自由基吸收活性。此外,化合物在低浓度下能显著保护PC12神经元免受H₂O₂诱导的细胞死亡。细胞毒性试验表明,低浓度的衍生物不影响SH - SY5Y神经元的活力。因此,这些橙皮素衍生物是用于治疗阿尔茨海默病进一步开发的潜在多功能药物。